NO165401C - Fremgangsmaate til fremstilling av dinatrium-3-amino-1-hydroksypropan-1,1-difosfonat i krystallinsk, krystallvannholdig form. - Google Patents

Fremgangsmaate til fremstilling av dinatrium-3-amino-1-hydroksypropan-1,1-difosfonat i krystallinsk, krystallvannholdig form.

Info

Publication number
NO165401C
NO165401C NO853087A NO853087A NO165401C NO 165401 C NO165401 C NO 165401C NO 853087 A NO853087 A NO 853087A NO 853087 A NO853087 A NO 853087A NO 165401 C NO165401 C NO 165401C
Authority
NO
Norway
Prior art keywords
crystally
crystallic
dinatrium
diphosphonate
hydroxypropane
Prior art date
Application number
NO853087A
Other languages
English (en)
Norwegian (no)
Other versions
NO853087L (no
NO165401B (no
Inventor
Peter Heinrich Stahl
Beat Schmitz
Original Assignee
Ciba Geigy Ag
Henkel Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4263070&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO165401(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag, Henkel Kgaa filed Critical Ciba Geigy Ag
Publication of NO853087L publication Critical patent/NO853087L/no
Priority to NO902523A priority Critical patent/NO171111C/no
Publication of NO165401B publication Critical patent/NO165401B/no
Publication of NO165401C publication Critical patent/NO165401C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO853087A 1984-08-06 1985-08-05 Fremgangsmaate til fremstilling av dinatrium-3-amino-1-hydroksypropan-1,1-difosfonat i krystallinsk, krystallvannholdig form. NO165401C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO902523A NO171111C (no) 1984-08-06 1990-06-07 Fremgangsmaate til fremstilling av en ny krystallmodifikasjon av dinatrium-3-amino-1-hydroksypropan-1,1-difosfonat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH376884 1984-08-06

Publications (3)

Publication Number Publication Date
NO853087L NO853087L (no) 1986-02-07
NO165401B NO165401B (no) 1990-10-29
NO165401C true NO165401C (no) 1991-02-06

Family

ID=4263070

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853087A NO165401C (no) 1984-08-06 1985-08-05 Fremgangsmaate til fremstilling av dinatrium-3-amino-1-hydroksypropan-1,1-difosfonat i krystallinsk, krystallvannholdig form.

Country Status (26)

Country Link
US (2) US4639338A (ru)
EP (1) EP0177443B1 (ru)
JP (1) JPS6143196A (ru)
KR (1) KR940000817B1 (ru)
AR (4) AR240832A1 (ru)
AT (1) ATE47396T1 (ru)
AU (1) AU591066B2 (ru)
CA (1) CA1255694A (ru)
CY (1) CY1570A (ru)
DD (1) DD239597A5 (ru)
DE (1) DE3573783D1 (ru)
DK (1) DK167282B1 (ru)
DO (1) DOP1990004769A (ru)
ES (2) ES8701188A1 (ru)
FI (1) FI79712C (ru)
GR (1) GR851910B (ru)
HK (1) HK42591A (ru)
HU (1) HU193124B (ru)
IE (1) IE58077B1 (ru)
IL (1) IL75990A (ru)
MX (1) MX9203373A (ru)
NO (1) NO165401C (ru)
PH (1) PH24854A (ru)
PT (1) PT80916B (ru)
SG (1) SG91390G (ru)
ZA (1) ZA855892B (ru)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.
EP0243173B1 (en) * 1986-04-24 1991-06-26 Fujisawa Pharmaceutical Co., Ltd. New diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
TW237386B (ru) 1992-04-15 1995-01-01 Ciba Geigy
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
JP3266395B2 (ja) * 1993-11-24 2002-03-18 富士写真フイルム株式会社 有機薬品の晶析方法
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
PT891979E (pt) * 1997-07-15 2005-02-28 Gador Sa Uma forma cristalina do mono-hidrato do sal monossodico do acido n,n-dimetil-3-amino-1-hidroxipropan-1,1-difosfonico e o procedimento para a sua preparacao
EP1702924A3 (en) * 1998-08-27 2007-07-18 Teva Pharmaceutical Industries Ltd Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
DE69932620T2 (de) * 1998-08-27 2006-12-14 Teva Pharmaceutical Industries Ltd. Hydratformen des natriumsalzes von alendronat, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten
EP0998933A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
US6794536B1 (en) 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
ATE238315T1 (de) * 1998-12-10 2003-05-15 Aesgen Inc Verfahren zur herstellung von dinatriumpamidronat
US6160165A (en) 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
US6963008B2 (en) * 1999-07-19 2005-11-08 Teva Pharmaceutical Industries Ltd. Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
ES2153794B1 (es) * 1999-08-06 2001-10-16 Medichem Sa Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada.
KR100343232B1 (ko) * 1999-12-10 2002-07-10 김재윤 결정성 파미드론산 이나트륨염 수화물과 그의 제조방법
EP1318818A4 (en) * 2000-09-18 2004-09-29 Faulding F H & Co Ltd Diphosphonate SOLUTIONS
DE60111574T2 (de) * 2001-01-23 2006-05-11 Gador S.A. Bisphosphonate enthaltende Zusammensetzungen zur Vorbeugung und/oder Heilung von metabolischen Knochenkrankheiten, Verfahren zu ihrer Herstellung und Benutzung dieser Zusammensetzungen
PL363537A1 (en) 2001-05-02 2004-11-29 Sicor Inc. Injectable pamidronate disodium
CA2347330C (en) * 2001-05-10 2002-03-12 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
ITMI20012751A1 (it) * 2001-12-21 2003-06-21 Lyogen Ltd Sale monosodico dell'acido pamidronico e procedimento per la sua preparazione
NZ534104A (en) * 2001-12-24 2007-03-30 Teva Pharma Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
EP1790347B1 (en) * 2002-12-20 2014-12-24 F. Hoffmann-La Roche AG High dose ibandronate formulation
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
AU2003286309A1 (en) * 2003-12-04 2005-06-24 Mustafa Nevzat Ilac Sanayii A.S. Method for producing pure disodium pamidronate
JP4605221B2 (ja) 2004-05-24 2011-01-05 味の素株式会社 キレート剤を含有するビスホスホネートの腸溶性で固形の経口剤形
WO2006039721A2 (en) * 2004-10-08 2006-04-13 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
WO2008128056A1 (en) * 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
AU2007226964B2 (en) * 2006-03-17 2012-03-22 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
EP2136814A4 (en) * 2007-03-21 2012-05-30 Univ Duke MEDICAL KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES FROM A PREVIOUS FRACTURE
JP2011517313A (ja) 2007-12-11 2011-06-02 ビアメト ファーマシューティカルズ，インク． 金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
US9867838B2 (en) 2009-09-01 2018-01-16 Duke University Methods for treating heart failure using bisphosphonate compositions
FR2954320B1 (fr) 2009-12-17 2012-06-15 Cll Pharma Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
US20130138221A1 (en) 2010-04-16 2013-05-30 Novartis Ag Methods and compositions for improving implant osseointegration
CN104010647A (zh) 2011-11-16 2014-08-27 杜克大学 用于治疗和/或减轻心功能障碍的双膦酸盐组合物及方法
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
EP2849758B1 (en) * 2012-05-14 2018-04-04 Antecip Bioventures II LLC Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions
US11654152B2 (en) 2012-05-14 2023-05-23 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
KR101995432B1 (ko) * 2016-10-13 2019-07-02 엘지전자 주식회사 공기조화기 및 그 제어방법
EP3553067A1 (en) * 2018-04-10 2019-10-16 Abiogen Pharma S.p.A. Polymorph of sodium neridronate and preparation process thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130794C3 (de) * 1971-06-22 1974-07-11 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von l-Hydroxy-S-amino-propan-ljl-diphosphonsäure
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4134969A (en) * 1974-02-04 1979-01-16 Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) Method of treatment of calcium disorders using aminoalkane-diphosphonic acids
DE2534391C2 (de) * 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
DE2553963A1 (de) * 1975-12-01 1977-06-08 Henkel & Cie Gmbh Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
JPS5283957A (en) * 1975-12-01 1977-07-13 Henkel & Cie Gmbh Medicine for treating metabolic obstruction of calcium
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
DE2702631A1 (de) * 1977-01-22 1978-07-27 Henkel Kgaa Verfahren zur herstellung von 1-hydroxy-3-amino-propan-1,1-diphosphonsaeuren
DE2943498C2 (de) * 1979-10-27 1983-01-27 Henkel KGaA, 4000 Düsseldorf Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsäure
DE3016289A1 (de) * 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
US4304734A (en) * 1980-10-16 1981-12-08 Vysoka Skola Chemicko-Technologicka 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof
DE3151038A1 (de) * 1981-12-23 1983-07-28 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von 3-amino-1-hydroxypropan-1,1-diphosphonsaeure
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
KR860001821A (ko) 1986-03-22
US4711880A (en) 1987-12-08
PT80916B (pt) 1987-12-30
PT80916A (en) 1985-09-01
AR240832A2 (es) 1991-02-28
IE851931L (en) 1986-02-06
HU193124B (en) 1987-08-28
GR851910B (ru) 1985-12-03
ATE47396T1 (de) 1989-11-15
FI852986A0 (fi) 1985-08-02
DK167282B1 (da) 1993-10-04
DK355485D0 (da) 1985-08-05
AR240832A1 (es) 1991-02-28
DK355485A (da) 1986-02-07
CY1570A (en) 1991-12-20
ES8701188A1 (es) 1986-11-16
NO853087L (no) 1986-02-07
NO165401B (no) 1990-10-29
HK42591A (en) 1991-06-07
EP0177443A1 (de) 1986-04-09
ZA855892B (en) 1986-03-26
AU4577785A (en) 1986-02-13
JPS6143196A (ja) 1986-03-01
ES555602A0 (es) 1987-07-01
PH24854A (en) 1990-12-26
DOP1990004769A (es) 1999-08-19
JPH058717B2 (ru) 1993-02-02
US4639338A (en) 1987-01-27
ES8706707A1 (es) 1987-07-01
IE58077B1 (en) 1993-06-30
SG91390G (en) 1991-01-18
KR940000817B1 (ko) 1994-02-02
AR244696A1 (es) 1993-11-30
FI79712C (fi) 1990-02-12
FI79712B (fi) 1989-10-31
MX9203373A (es) 1992-09-01
EP0177443B1 (de) 1989-10-18
AR244697A1 (es) 1993-11-30
AU591066B2 (en) 1989-11-30
IL75990A (en) 1989-07-31
HUT38361A (en) 1986-05-28
DD239597A5 (de) 1986-10-01
ES545899A0 (es) 1986-11-16
AR244698A1 (es) 1993-11-30
CA1255694A (en) 1989-06-13
DE3573783D1 (en) 1989-11-23
FI852986L (fi) 1986-02-07

Similar Documents

Publication Publication Date Title
NO853087L (no) Fremgangsmaate til fremstilling av dinatrium-3-amino-1-hydroksy-propan-1,1-difosfonat i krystallinsk krystallvannholdig form.
NO873205L (no) Fremgangsmaate for fremstilling av carbapenemforbindelser i krystallinsk form.
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO852025L (no) Fremgangsmaate til fremstilling av 7-amino-1-cyklopropyl-6,8-dihalogen-1,4-dihydro-4-okso-3-chinolinkarboksylsyre.
NO164595C (no) Fremgangsmaate til fremstilling av vandige n-metylmorfolin-n-oksid-opploesninger.
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO159080C (no) Fremgangsmaate til fremstilling av 2,4-diklor-5-fluor-benzosyre.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
FI850197A0 (fi) Foerfarande foer kontroll av byggdelar med hjaelp av en virvelstroem, i synnerhet i kaerntekniska anlaeggningar.
NO863343L (no) Fremgangsmaate for fremstilling av gem-dihalo-1,8-diamino-4-aza-octaner.
NO860273L (no) Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner.
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
NO874617D0 (no) Fremgangsmaate til fremstilling av 2,6-diamino-3-halogenobenzylpyridiner.
NO863344D0 (no) Fremgangsmaate for fremstilling av gem-dihalo- og tetrahalo-1,2-diamino-4,9-diaza-dodecaner.
NO851766L (no) Fremstilling av pastiller.
MX162258A (es) Procedimiento de preparacion de acidos dihidro-5,6-4h-ciclopenta/b/tiofencarboxilicos-6
NO863045D0 (no) Fremgangsmaate for fremstilling av alkyl-2-karboalkoksy-3,4-dialkoksybenzenkarbamater.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.
NO851319L (no) Fremgangsmaate for fremstilling av eburnanderivater.
ES547820A0 (es) Procedimiento de preparacion de nuevos derivados nucleosidos.
NO861178L (no) Fremgangsmaate for fremstilling av 1,8-nafthyridinoner.
NO864305D0 (no) Fremgangsmaate for fremstilling av 5-nafthyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO903304L (no) Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO903305D0 (no) Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.

Legal Events

Date Code Title Description
MK1K Patent expired